These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 18505832

  • 1. The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.
    Rigazio S, Lehto HR, Tuunanen H, Någren K, Kankaanpaa M, Simi C, Borra R, Naum AG, Parkkola R, Knuuti J, Nuutila P, Iozzo P.
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E413-9. PubMed ID: 18505832
    [Abstract] [Full Text] [Related]

  • 2. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
    Rijkelijkhuizen JM, Doesburg T, Girman CJ, Mari A, Rhodes T, Gastaldelli A, Nijpels G, Dekker JM.
    Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
    [Abstract] [Full Text] [Related]

  • 3. Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
    Carey PE, Gerrard J, Cline GW, Dalla Man C, English PT, Firbank MJ, Cobelli C, Taylor R.
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E941-7. PubMed ID: 15998660
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.
    Lam TK, Yoshii H, Haber CA, Bogdanovic E, Lam L, Fantus IG, Giacca A.
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E682-91. PubMed ID: 12217885
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
    Lam TK, van de Werve G, Giacca A.
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
    [Abstract] [Full Text] [Related]

  • 8. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
    Rijzewijk LJ, Jonker JT, van der Meer RW, Lubberink M, de Jong HW, Romijn JA, Bax JJ, de Roos A, Heine RJ, Twisk JW, Windhorst AD, Lammertsma AA, Smit JW, Diamant M, Lamb HJ.
    J Am Coll Cardiol; 2010 Jul 13; 56(3):225-33. PubMed ID: 20620743
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.
    Krag MB, Gormsen LC, Guo Z, Christiansen JS, Jensen MD, Nielsen S, Jørgensen JO.
    Am J Physiol Endocrinol Metab; 2007 Mar 13; 292(3):E920-7. PubMed ID: 17132823
    [Abstract] [Full Text] [Related]

  • 14. Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels.
    Lehto HR, Pärkkä J, Borra R, Tuunanen H, Lepomaki V, Parkkola R, Knuuti J, Nuutila P, Iozzo P.
    J Clin Endocrinol Metab; 2012 Sep 13; 97(9):3277-84. PubMed ID: 22761459
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of lipolysis does not affect insulin sensitivity to glucose uptake in the mourning dove.
    Sweazea KL, McMurtry JP, Braun EJ.
    Comp Biochem Physiol B Biochem Mol Biol; 2006 Jul 13; 144(3):387-94. PubMed ID: 16753324
    [Abstract] [Full Text] [Related]

  • 16. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
    Park E, Wong V, Guan X, Oprescu AI, Giacca A.
    J Endocrinol; 2007 Nov 13; 195(2):323-31. PubMed ID: 17951543
    [Abstract] [Full Text] [Related]

  • 17. [Macronutrients, fat mass, fatty acid flux and insulin sensitivity].
    Ziegler O, Quilliot D, Guerci B, Drouin P.
    Diabetes Metab; 2001 Apr 13; 27(2 Pt 2):261-70. PubMed ID: 11452220
    [Abstract] [Full Text] [Related]

  • 18. Short-term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated.
    Johnson NA, Stannard SR, Rowlands DS, Chapman PG, Thompson CH, Sachinwalla T, Thompson MW.
    Diabet Med; 2006 Oct 13; 23(10):1061-8. PubMed ID: 16978369
    [Abstract] [Full Text] [Related]

  • 19. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U.
    Exp Clin Endocrinol Diabetes; 2003 Aug 13; 111(5):246-50. PubMed ID: 12951628
    [Abstract] [Full Text] [Related]

  • 20. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.
    Gastaldelli A, Casolaro A, Ciociaro D, Frascerra S, Nannipieri M, Buzzigoli E, Ferrannini E.
    Am J Physiol Endocrinol Metab; 2009 Jul 13; 297(1):E225-30. PubMed ID: 19417125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.